51 In vitro and in vivo activity of sacituzumab govitecan, in ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regional plenary

North America Regional Plenary

IGCS19-0373

51 In vitro and in vivo activity of sacituzumab govitecan, in ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: September 2019 to March 2023

	Abstract	Full	Pdf
Sep 2019	22	0	7
Oct 2019	36	0	9
Nov 2019	26	0	4
Dec 2019	16	0	3
Jan 2020	22	0	3
Feb 2020	18	0	4
Mar 2020	32	0	3
Apr 2020	52	0	8
May 2020	78	0	2
Jun 2020	76	0	3
Jul 2020	130	0	5
Aug 2020	114	0	1
Sep 2020	40	0	2
Oct 2020	22	0	1
Nov 2020	21	0	5
Dec 2020	36	0	5
Jan 2021	19	0	1
Feb 2021	32	0	3
Mar 2021	18	0	4
Apr 2021	16	0	3
May 2021	5	0	2
Jun 2021	2	0	3
Jul 2021	0	0	3
Aug 2021	0	0	10
Sep 2021	0	0	2
Oct 2021	18	0	22
Nov 2021	18	0	13
Dec 2021	28	0	15
Jan 2022	12	0	4
Feb 2022	18	0	8
Mar 2022	26	0	4
Apr 2022	10	0	4
May 2022	22	0	16
Jun 2022	20	0	5
Jul 2022	21	0	2
Aug 2022	14	0	3
Sep 2022	12	0	8
Oct 2022	28	0	3
Nov 2022	10	0	2
Dec 2022	12	0	1
Jan 2023	10	0	4
Feb 2023	14	0	4
Mar 2023	4	0	1
Total	1130	0	215